Carboplatin and Haemorrhagic diathesis - a phase IV clinical study of FDA data

Summary:

Haemorrhagic diathesis is reported as a side effect among people who take Carboplatin (carboplatin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Zofran, and have Ovarian cancer.

The phase IV clinical study analyzes which people have Haemorrhagic diathesis when taking Carboplatin. It is created by eHealthMe based on reports of 127,949 people who have side effects when taking Carboplatin from the FDA, and is updated regularly.

What is Carboplatin?

Carboplatin has active ingredients of carboplatin. It is often used in cancer. eHealthMe is studying from 128,210 Carboplatin users. Check the latest studies of Carboplatin.

What is Haemorrhagic diathesis?

Haemorrhagic diathesis (bleeding tendency) is found to be associated with 530 drugs and 672 conditions by eHealthMe. Check the latest studies of Haemorrhagic diathesis.

On Jul, 14, 2026

127,949 people reported to have side effects when taking Carboplatin.
Among them, 31 people (0.02%) have Haemorrhagic diathesis.

Could Carboplatin cause Haemorrhagic diathesis?

Among these 31 people:

How long have people been on Carboplatin when they have Haemorrhagic diathesis? *

What is the gender of people who have Haemorrhagic diathesis when taking Carboplatin? *

female: 83.33 %
male: 16.67 %

What is the age of people who have Haemorrhagic diathesis when taking Carboplatin? *

What are other drugs people take besides Carboplatin? *

What are other side effects people have besides Haemorrhagic diathesis? *

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 14 people, 45.16%
Nosebleed (bleeding from nose): 13 people, 41.94%
Lymphorrhea: 9 people, 29.03%
Anaemia (lack of blood): 9 people, 29.03%
Staphylococcal Infection (an infection with staphylococcus bacteria): 9 people, 29.03%
Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 9 people, 29.03%
Thrombocytopenia (decrease of platelets in blood): 8 people, 25.81%
Headache (pain in head): 8 people, 25.81%
Fever: 7 people, 22.58%
Gingival Bleeding (bleeding gums): 7 people, 22.58%

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 11 people, 35.48%
Infusion Related Reaction: 9 people, 29.03%
Ovarian Cancer Stage Iv: 4 people, 12.90%
Breast Cancer: 4 people, 12.90%
Ovarian Epithelial Cancer (cancer that begins in the cells on the surface of the ovary): 3 people, 9.68%
T-Cell Lymphoma (a blood cell cancer): 2 people, 6.45%
Stable Angina (a constant chest pain): 2 people, 6.45%
Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 1 person, 3.23%
Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 1 person, 3.23%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 3.23%

* Approximation only. Some reports may have incomplete information.

Do you take Carboplatin and have Haemorrhagic diathesis?

- Check whether Haemorrhagic diathesis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carboplatin:

Carboplatin (128,210 reports)

Browse all side effects of Carboplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemorrhagic diathesis:

Haemorrhagic diathesis (530 drugs)

Browse all the conditions that are associated with Haemorrhagic diathesis:

Haemorrhagic diathesis (672 conditions)

Related publications that referenced our studies

Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .
Zakaria S, Lu KY, Nussenblatt V, Browner I, "Atrial flutter associated with carboplatin administration", Annals of Pharmacotherapy, 2011 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on carboplatin (the active ingredients of Carboplatin) and Carboplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.